Dose intensity of nab-paclitaxel and gemcitabine chemotherapy in metastatic pancreatic cancer

被引：3
|
作者：
Lim, Alexander
Kim, Dae Won
Kim, Kunhwa
Kim, Richard D.
Bottiglieri, Salvatore Michael
机构：
[1] Univ S Florida, Dept Internal Med, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.251
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
251
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase II study of nab-paclitaxel and gemcitabine in Korean patients with metastatic pancreatic cancer
    Lee, S. J.
    Oh, D-Y.
    Kang, J-H.
    Choi, H. J.
    Lee, M. A.
    Oh, S. Y.
    Kim, S-T.
    Park, Y. S.
    Ryu, B-Y.
    Park, J. O.
    ANNALS OF ONCOLOGY, 2018, 29
  • [22] A nomogram to predict neutropenia in metastatic pancreatic cancer patients treated with gemcitabine/nab-paclitaxel
    Morelli, C.
    Formica, V.
    Nardecchia, A.
    Lucchetti, J.
    Tisone, G.
    Anselmo, A.
    Blanco, C. Del Vecchio
    Benassi, M.
    Palmieri, G.
    Argiro, R.
    Roselli, M.
    ANNALS OF ONCOLOGY, 2019, 30
  • [23] Combination chemotherapy with gemcitabine and nab-paclitaxel for a metastatic pancreatic ductal adenocarcinoma patient undergoing hemodialysis
    Kaneko, Takashi
    Sugimori, Kazuya
    Tozuka, Yuichiro
    Fukushima, Taito
    Okada, Kazuya
    Oka, Hiroyuki
    Okazaki, Hiroshi
    Maeda, Shin
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2019, 12 (05) : 484 - 489
  • [24] Triptolide in Combination with Low Dose Gemcitabine and Nab-Paclitaxel: A Novel Effective Combination Chemotherapy Regimen for Pancreatic Cancer
    Modi, Shrey
    Giri, Bhuwan
    Garg, Bharti
    George, John
    Sethi, Vrishketan
    Banerjee, Sulagna
    Dudeja, Vikas
    Saluja, Ashok
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 223 (04) : E49 - E49
  • [25] Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer
    Giandomenico Roviello
    Monica Ramello
    Martina Catalano
    Alberto D’Angelo
    Raffaele Conca
    Silvia Gasperoni
    Lorenzo Dreoni
    Roberto Petrioli
    Anna Ianza
    Stefania Nobili
    Michele Aieta
    Enrico Mini
    Scientific Reports, 10
  • [26] Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
    Hakon Blomstrand
    Ursula Scheibling
    Charlotte Bratthäll
    Henrik Green
    Nils O. Elander
    BMC Cancer, 19
  • [27] Association between neutropenia and survival to nab-paclitaxel and gemcitabine in patients with metastatic pancreatic cancer
    Roviello, Giandomenico
    Ramello, Monica
    Catalano, Martina
    D'Angelo, Alberto
    Conca, Raffaele
    Gasperoni, Silvia
    Dreoni, Lorenzo
    Petrioli, Roberto
    Ianza, Anna
    Nobili, Stefania
    Aieta, Michele
    Mini, Enrico
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [28] Progressive digital necrosis during gemcitabine/nab-paclitaxel chemotherapy in a patient with pancreatic cancer
    Shimizu, Yuri
    Ohata, Chika
    DERMATOLOGIC THERAPY, 2022, 35 (04)
  • [29] Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
    Blomstrand, Hakon
    Scheibling, Ursula
    Bratthall, Charlotte
    Green, Henrik
    Elander, Nils O.
    BMC CANCER, 2019, 19 (1)
  • [30] A modified regimen of nab-paclitaxel and gemcitabine in advanced pancreatic cancer
    Osman, M. A. M.
    McDermott, R.
    Fennelly, D.
    ANNALS OF ONCOLOGY, 2016, 27
12345